Stay updated with breaking news from Nasdaq Cemi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Chembio Diagnostics, Inc. (NASDAQ:CEMI – Get Rating) was the target of a significant decrease in short interest during the month of March. As of March 15th, there was short interest totalling 327,400 shares, a decrease of 62.7% from the February 28th total of 876,600 shares. Based on an average daily volume of 660,400 shares, the […]
StockNews.com assumed coverage on shares of Chembio Diagnostics (NASDAQ:CEMI – Get Rating) in a research report sent to investors on Tuesday. The brokerage issued a hold rating on the stock. Chembio Diagnostics Stock Performance Shares of CEMI stock opened at $0.39 on Tuesday. Chembio Diagnostics has a 52-week low of $0.19 and a 52-week high […]
StockNews.com assumed coverage on shares of Chembio Diagnostics (NASDAQ:CEMI – Get Rating) in a research report issued to clients and investors on Saturday. The firm set a “sell” rating on the stock. Other equities research analysts have also issued reports about the stock. Zacks Investment Research lowered shares of Chembio Diagnostics from a “hold” rating […]
HAUPPAUGE, N.Y., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on...